Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer - Report of a Canadian multicenter randomized trial

Journal of Clinical Oncology

Volumn 6, Issue 4, 1988, Pages 633-641

  Rapp, E ^a   Pater, J L ^a   Willan, A ^a   Cormier, Y ^a   Murray, N ^a   Evans, W K ^a   Hodson, D I ^a   Clark, D A ^a   Feld, R ^a   Arnold, A M ^a   Ayoub, J I ^a   Wilson, K S ^a   Latreille, J ^a   Wierzbicki, R F ^a   Hill, D P ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; VINDESINE;

CONTROLLED STUDY; FATALITY; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; NEUROTOXICITY; PRIORITY JOURNAL; SURVIVAL;

EID: 0023922084     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1988.6.4.633     Document Type: Article

References (0)